Pharmaceutical Online Videos

  1. MilliporeSigma Capacity Update July 2025: Small Molecule Drug Substance/API 7/29/2025

    Applications specialist John Stevens shows how MilliporeSigma is using their 35+ years of CDMO experience and expertise to move customers’ small molecules forward to the clinic and beyond to commercialization.

  2. Amorphous Solid Dispersions: Pre-Clinical To Commercial Capabilities 7/29/2025

    ASDs are an attractive option for commercializing poorly soluble compounds. This talk focuses on capabilities to screen the potential for ASDs in early phase studies and their commercial applicability.

  3. Your Integrated Drug Substance Partner 7/29/2025

    With capabilities to support your next small molecule drug substance program from R&D to commercial scale, learn about our integrated facilities, project teams, and available capacity.

  4. Aragen Capacity Update July 2025: Small Molecule Drug Substance/API 7/28/2025

    Explore specialized expertise in solving challenging small molecule formulation problems (poor solubility, bioavailability, complex delivery routes).

  5. Providing Development And Supply Of Life-Changing Medicines 7/28/2025

    Review the strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Cutting-edge capabilities ensure streamlined development and manufacturing processes.

  6. Aragen Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L—scaling to 5000L soon—with a DP filling line and ADC conjugation suite set to redefine bioproduction in India.

  7. Afton Scientific Capacity Update July 2025: Fill/Finish 7/28/2025

    Gain an overview of a new state-of-the-art Groninger filling line’s capabilities, production scale-up timelines, and how this new infrastructure supports product flexibility and long-term growth for our partners in the injectable drug product space.

  8. MilliporeSigma Capacity Update July 2025: ADC 7/28/2025

    MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

  9. Integrated ADC Offering: From Concept To Commercialization 7/28/2025

    Leveraging deep ADC expertise and experience, successfully develop high quality, commercially viable processes, spanning from pre-clinical development through commercial scale manufacturing.

  10. Solid Formulation: Spray Drying Process 7/24/2025

    Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.